FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

900000000000526001: REPLACED BY association reference set (foundation metadata concept)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT model component module (core metadata concept)

Descriptions:

Id Description Lang Type Status Case? Module
900000000001156010 REPLACED BY association reference set (foundation metadata concept) en Fully specified name Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)
900000000001157018 REPLACED BY association reference set en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)


23369 members. Search Members:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
REPLACED BY association reference set (foundation metadata concept) Is a Historical association reference set (foundation metadata concept) true Inferred relationship Some

Members targetComponentId
Synovial fluid: appearance NOS Synovial fluid appearance
Synovial fluid: appearance NOS Synovial fluid appearance
Synovial fluid: joint NOS Synovial fluid specimen
Synovial fluid: joint NOS Synovial fluid specimen
Synovial osteochondromatosis of other tarsal joint Synovial osteochondromatosis
Synovial sarcoma - category Synovial sarcoma
Syntactical aphasia Syntactical aphasia (finding)
Synthetic antiandrogen Antiandrogen
Synthetic patch repair Repair - action
Syphilis titer test NOS Syphilis infectious titre test
Syphilitic gumma of other sites Syphilitic gumma
Syringing - action Irrigation - action (qualifier value)
Syringomyelobulbia Syringomyelia and syringobulbia
System analyst/computer programmer NOS Systems analyst/computer programmer
System analyst/computer programmer NOS Systems analyst/computer programmer
Systemic chondromalacia Relapsing polychondritis
Other acquired deformity of finger, NEC Deformity of phalanx of finger or thumb
Systemic chromomycosis Cutaneous chromoblastomycosis
Systemic inflammatory response syndrome associated with organ dysfunction Acute organ dysfunction due to systemic inflammatory response syndrome (disorder)
Systemic vascular resistance Systemic vascular resistance (observable entity)
Systemic vascular resistance Systemic vascular resistance (observable entity)
Systemic vascular resistance Systemic vascular resistance (observable entity)
Systemic vascular resistance Systemic vascular resistance (observable entity)
Sézary's disease of extranodal AND/OR solid organ site Sezary's disease
T tube cholangiogram Fluoroscopic T tube cholangiography with contrast
T-shaped fracture T-shaped fracture
T-zone lymphoma Peripheral T-cell lymphoma
T0 category American Joint Committee on Cancer cT0 (qualifier value)
T1 (I): Cervical carcinoma confined to uterus American Joint Committee on Cancer cT1 (qualifier value)
T1 (I): Endometrial tumor confined to corpus uteri American Joint Committee on Cancer cT1 (qualifier value)
T1 (I): Trophoblastic disease confined to uterus American Joint Committee on Cancer cT1 (qualifier value)
T1 (I): Tumor confined to vagina American Joint Committee on Cancer cT1 (qualifier value)
T1 (I): Tumor limited to fallopian tube(s) American Joint Committee on Cancer cT1 (qualifier value)
T1 (IA): Trophoblastic disease confined to uterus with no risk factors American Joint Committee on Cancer cT1 (qualifier value)
T1 (IB): Trophoblastic disease confined to uterus with one risk factor American Joint Committee on Cancer cT1 (qualifier value)
T1 (IC): Trophoblastic disease confined to uterus with two risk factors American Joint Committee on Cancer cT1 (qualifier value)
T1 category American Joint Committee on Cancer cT1 (qualifier value)
T1: Aerodigestive tract tumor < 2 cm in greatest dimension American Joint Committee on Cancer cT1 (qualifier value)
T1: Aerodigestive tract tumor < 2 cm in greatest dimension without extraparenchymal extension American Joint Committee on Cancer cT1 (qualifier value)
T1: Aerodigestive tract tumor confined to ethmoid with or without bone erosion American Joint Committee on Cancer cT1 (qualifier value)
T1: Aerodigestive tract tumor confined to nasopharynx American Joint Committee on Cancer cT1 (qualifier value)
T1: Breast tumor <= 2 cm in greatest dimension American Joint Committee on Cancer cT1 (qualifier value)
T1: Clinically inapparent prostate tumor not palpable or visible by imaging American Joint Committee on Cancer cT1 (qualifier value)
T1: Kidney tumor < 7.0 cm in greatest dimension limited to the kidney American Joint Committee on Cancer cT1 (qualifier value)
T1: Lung tumor 3 cm or less in greatest dimension, surrounded by lung or visceral pleura, without bronchoscopic evidence of invasion more proximal than the lobar bronchus American Joint Committee on Cancer cT1 (qualifier value)
T1: Solitary liver tumor < 2 cm; no vascular invasion American Joint Committee on Cancer cT1 (qualifier value)
T1: Testicular tumor limited to the testis and epididymis without vascular/lymphatic invasion (tumor may invade tunica albuginea but not tunica vaginalis) American Joint Committee on Cancer cT1 (qualifier value)
T1: Tumor invades lamina propria or submucosa American Joint Committee on Cancer cT1 (qualifier value)
T1: Tumor invades submucosa (colon/rectum) American Joint Committee on Cancer cT1 (qualifier value)
T1: Tumor limited to ampulla of Vater or sphincter of Oddi American Joint Committee on Cancer cT1 (qualifier value)
T1: Tumor limited to ipsilateral parietal and/or visceral pleura American Joint Committee on Cancer cT1 (qualifier value)
T1: Tumor limited to one subsite of hypo-pharynx and < 2 cm in greatest dimension American Joint Committee on Cancer cT1 (qualifier value)
T1: Tumor limited to one subsite of supraglottis with normal vocal cord mobility American Joint Committee on Cancer cT1 (qualifier value)
T1: Tumor limited to pancreas and < 2 cm in greatest dimension American Joint Committee on Cancer cT1 (qualifier value)
T1: Tumor limited to subglottis American Joint Committee on Cancer cT1 (qualifier value)
T1: Tumor limited to the antral mucosa with no erosion or destruction of bone American Joint Committee on Cancer cT1 (qualifier value)
T1: Tumor limited to vocal cord(s) (may involve anterior or posterior commissure) with normal mobility American Joint Committee on Cancer cT1 (qualifier value)
T1: Tumor size < 1 cm, limited to thyroid American Joint Committee on Cancer cT1 (qualifier value)
T1: Urinary tract tumor invades subepithelial connective tissue American Joint Committee on Cancer cT1 (qualifier value)
T1a (IA): Invasive carcinoma of uterine cervix diagnosed by microscopy only American Joint Committee on Cancer cT1a (qualifier value)
T1a (IA): Tumor limited to endometrium American Joint Committee on Cancer cT1a (qualifier value)
T1a (IA): Tumor limited to one fallopian tube without penetrating the serosal surface, no ascites American Joint Committee on Cancer cT1a (qualifier value)
T1a (IA): Tumor limited to one ovary, capsule intact, no tumor on ovarian surface American Joint Committee on Cancer cT1a (qualifier value)
T1a1 (IA1): Tumor of uterine cervix with stromal invasion < 3.0 mm in depth and horizontal spread < 7.0 mm American Joint Committee on Cancer cT1a1 (qualifier value)
T1a2 (IA2): Tumor of uterine cervix with stromal invasion > 3.0 mm but < 5.0 mm in depth and horizontal spread < 7.0 mm American Joint Committee on Cancer cT1a2 (qualifier value)
T1a: Breast tumor >0.1 cm but <= 0.5 cm in greatest dimension American Joint Committee on Cancer cT1a (qualifier value)
T1a: Esophagus/stomach tumor invades lamina propria American Joint Committee on Cancer cT1a (qualifier value)
T1a: Prostate tumor incidental histologic finding in 5 percent or less of tissue resected American Joint Committee on Cancer cT1a (qualifier value)
T1a: Tumor limited to one vocal cord American Joint Committee on Cancer cT1a (qualifier value)
T1b (IB): Endometrial tumor invades up to or less than one half of the endometrium American Joint Committee on Cancer cT1b (qualifier value)
T1b (IB): Tumor limited to both ovaries: capsule intact, no tumor on ovarian surface American Joint Committee on Cancer cT1b (qualifier value)
T1b (IB): Tumor limited to both tubes without penetrating the serosal surface: no ascites American Joint Committee on Cancer cT1b (qualifier value)
T1b (IB): Tumor of uterine cervix with clinically visible lesion confined to the cervix or microscopic lesion greater than T1a2/IA2 American Joint Committee on Cancer cT1b (qualifier value)
T1b1 (IB1): Tumor of uterine cervix, clinically visible lesion < 4.0 mm in greatest dimension American Joint Committee on Cancer cT1b1 (qualifier value)
T1b2 (IB2): Tumor of uterine cervix, clinically visible lesion > 4.0 mm in greatest dimension American Joint Committee on Cancer cT1b2 (qualifier value)
T1b: Breast tumor >0.5 cm but <= 1 cm in greatest dimension American Joint Committee on Cancer cT1b (qualifier value)
T1b: Esophagus/stomach tumor invades submucosa American Joint Committee on Cancer cT1b (qualifier value)
T1b: Prostate tumor incidental histologic finding in greater than 5 percent of tissue resected American Joint Committee on Cancer cT1b (qualifier value)
T1b: Tumor involves both vocal cords American Joint Committee on Cancer cT1b (qualifier value)
T1c (IC): Endometrial tumor invades to more than one half of the endometrium American Joint Committee on Cancer cT1c (qualifier value)
T1c (IC): Tumor limited to one or both ovaries with any of the following: capsule ruptured, tumor on ovarian surface, malignant cells in ascites or peritoneal washings: OVARY: Resection American Joint Committee on Cancer cT1c (qualifier value)
T1c (IC): Tumor limited to one or both tube(s) with extension into or through the tubal serosa; or with malignant cells in ascites or peritoneal washings: FALLOPIAN TUBE: Salpingectomy American Joint Committee on Cancer cT1c (qualifier value)
T1c: >1 cm but <= 2 cm in greatest dimension: BREAST: Complete excision less than total mastectomy, total mastectomy, modified radical mastectomy, radical mastectomy American Joint Committee on Cancer cT1c (qualifier value)
T1c: Tumor identified by needle biopsy because of elevated prostate specific antigen: PROSTATE: Biopsy/transurethral resection: PROSTATE: Resection American Joint Committee on Cancer cT1c (qualifier value)
T1mic: Microinvasion <= 0.1 cm in greatest dimension: BREAST: Complete excision less than total mastectomy, total mastectomy, modified radical mastectomy, radical mastectomy American Joint Committee on Cancer cT1mi (qualifier value)
T2 (II): Endometrial tumor invades cervix, but does not extend beyond uterus American Joint Committee on Cancer cT2 (qualifier value)
T2 (II): Fallopian tube tumor involves one or both tube(s) with pelvic extension American Joint Committee on Cancer cT2 (qualifier value)
T2 (II): Trophoblast: gestational trophoblastic tumor extends outside of the uterus but is limited to the genital structures (adnexa, vagina, broad ligament) American Joint Committee on Cancer cT2 (qualifier value)
T2 (II): Tumor of uterine cervix invades beyond the uterus but not to pelvic wall or to lower third of vagina American Joint Committee on Cancer cT2 (qualifier value)
T2 (II): Vaginal tumor invades paravaginal tissues but not to pelvic wall American Joint Committee on Cancer cT2 (qualifier value)
T2 (IIA): Trophoblast: gestational trophoblastic tumor involving genital structure without risk factors American Joint Committee on Cancer cT2 (qualifier value)
T2 (IIB): Trophoblast: gestational trophoblastic tumor extends outside of the uterus but limited to genital structures with one risk factor American Joint Committee on Cancer cT2 (qualifier value)
T2 (IIC): Trophoblast: gestational trophoblastic tumor extends outside of the uterus but limited to genital structures with two risk factors American Joint Committee on Cancer cT2 (qualifier value)
T2 category American Joint Committee on Cancer cT2 (qualifier value)
T2: Aerodigestive tract tumor > 2 cm but < 4 cm in greatest dimension American Joint Committee on Cancer cT2 (qualifier value)
T2: Aerodigestive tract tumor > 2 cm but < 4 cm in greatest dimension without extraparenchymal extension American Joint Committee on Cancer cT2 (qualifier value)
T2: Aerodigestive tract tumor causing bone erosion or destruction, except for the posterior antral wall, including extension into hard palate and/or middle nasal meatus American Joint Committee on Cancer cT2 (qualifier value)
T2: Aerodigestive tract tumor extends into nasal cavity American Joint Committee on Cancer cT2 (qualifier value)
T2: Aerodigestive tract tumor extends to soft tissue of oropharynx and/or nasal fossa American Joint Committee on Cancer cT2 (qualifier value)
T2: Aerodigestive tract tumor extends to supraglottis and/or subglottis, and/or with impaired vocal cord mobility American Joint Committee on Cancer cT2 (qualifier value)
T2: Aerodigestive tract tumor extends to vocal cord(s) with normal or impaired mobility American Joint Committee on Cancer cT2 (qualifier value)

Start Previous Page 205 of 234 Next End


Reference Sets

Reference set descriptor

Back to Start